查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2149052

女性健康市場規模、佔有率、成長及全球產業分析、區域洞察與預測（2026年至2034年）

Women's Health Market Size, Share, Growth and Global Industry Analysis, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 179 Pages | 商品交期: 2-3個工作天內

價格

女性健康市場的成長要素

受女性健康問題日益普遍以及人們對診斷、預防和治療意識不斷提高的推動，全球女性健康市場正經歷穩定成長。報告顯示，2025年全球女性健康市場規模為568.5億美元。預計到2026年，該市場規模將達到604.4億美元，到2034年將達到986.1億美元，預測期內複合年成長率（CAGR）為6.31%。 2025年，北美地區以51.4%的市佔率領先，醫療費用支出、女性健康產品的廣泛普及、先進的醫療基礎設施以及女性健康問題日益普遍。

女性健康領域涵蓋針對乳癌、骨質疏鬆症、更年期、不孕症、避孕以及其他生殖和健康相關議題的醫療保健產品和療法。擴大宣傳活動、推出新產品、加強公司間合作以及製藥公司的投資都在推動市場發展。

市場定義和範圍

女性健康市場涵蓋專為滿足女性醫療需求而設計的藥品和醫療保健解決方案。主要應用領域包括避孕、骨質疏鬆症、更年期、不孕症和其他女性健康問題。

該市場還包括透過醫院藥房、零售藥房和線上藥房進行分銷。由於預防性醫療保健、早期診斷、生殖健康服務和專科治療的日益普及，該市場在已開發國家和新興國家都在不斷擴張。

市場動態

促進因素

女性特有疾病的日益增多以及女性健康意識的不斷提高是推動市場成長的主要因素。乳癌、骨質疏鬆症、貧血、更年期症狀和不孕症等疾病促使對專業治療的需求不斷成長。早期診斷和預防醫學意識的提高促使女性尋求合適的醫療保健服務。

宣傳宣傳活動和醫療保健計畫也為這些措施的推廣提供了支持。鑑於女性骨質疏鬆症發病率不斷上升以及乳癌在全球造成的沉重負擔，製藥公司和醫療機構正積極努力擴大治療範圍並進行宣傳活動。

趨勢

一個顯著的市場趨勢是，市場參與者之間的策略聯盟和收購活動日益增多。各公司正透過夥伴關係、收購和產品商業化來強化其女性健康產品組合。拜耳收購KaNDy Therapeutics公司，增強了其在更年期治療領域的實力。其他製藥公司也在透過策略交易拓展其女性健康產品線。

人們對專業生殖醫學和創新療法的興趣日益濃厚，這也影響著女性健康市場的趨勢。

阻礙因素

某些女性保健產品的不良反應和潛在副作用可能會阻礙市場成長。口服避孕藥可能導致不規則出血、乳房疼痛、噁心和頭痛。有些骨質疏鬆症藥物也會引起副作用，某些藥物還可能有心血管風險。這些顧慮可能會影響治療選擇，並限制某些產品的普及。

新冠疫情的影響

新冠疫情初期對女性健康市場造成了負面影響。封鎖措施、醫療限制、非必要治療的延遲以及門診就診量的減少都影響了藥品銷售。例如，拜耳公司報告稱，由於治療取消和延遲的影響，其藥品銷售額下降了8.8%。

此外，病患購買行為的改變也對市場產生了影響，有些病患由於擔心感染新冠病毒，寧願購買藥品也不願去醫院就診。然而，對基本醫療產品的需求以及醫療機構的逐步重新開放支撐了市場的復甦。

細分分析

按應用領域分類，避孕藥具佔市場主導地位，預計到2025年將佔市場佔有率的34.2%。這一成長主要得益於人們對生殖健康意識的提高、對避孕產品的需求以及製藥公司推出新產品。骨質疏鬆症領域佔第二大市場佔有率，這主要得益於女性骨質疏鬆症盛行率的上升和醫療保健支出的增加。

就分銷管道而言，醫院藥房佔市場主導地位，因為許多藥品需要處方箋或由合格的專業人員進行醫療評估。政府對醫院基礎設施的投資進一步推動了這一領域的發展。同時，由於其便利性、可近性和折扣優惠，預計線上藥局也將快速成長。

區域分析

北美引領全球女性健康市場，預計到 2025 年將達到 180 億美元。強勁的醫療費用支出、女性健康產品的高滲透率、先進的基礎設施以及乳癌等疾病的高發病率都支撐了該地區的主導地位。

歐洲市場規模位居第二，這得益於人們對女性健康問題的日益關注以及完善的醫療衛生基礎設施。亞太地區預計將實現最高成長率，這主要得益於人們健康意識的提高、醫療支出的增加以及中國和印度等新興經濟體政府的各項舉措。拉丁美洲、中東和非洲市場規模相對小規模，但由於巨大的潛在需求，蘊藏著巨大的商機。

本報告對全球女性健康市場進行了全面分析，涵蓋市場規模、成長要素、趨勢、限制、應用、分銷管道、區域洞察、競爭格局以及2025年、2026年和2034年的關鍵行業趨勢。報告還重點關注女性健康關鍵類別的新興市場機會和產品開發活動。

單價（10億美元）

細分：應用、通路、區域

用途別

  • 避孕藥
  • 骨質疏鬆症
  • 停經
  • 不孕症
  • 其他

按銷售管道

  • 醫院藥房
  • 零售藥房
  • 網路藥房

按地區

  • 北美洲
    • 用途別
    • 透過分銷管道
    • 國家
  • 美國（透過申請）
  • 加拿大（按使用情況）
  • 歐洲
    • 用途別
    • 按銷售管道
    • 按國家/次區域
  • 英國（依使用情況）
  • 德國（透過申請）
  • 法國（依使用情況）
  • 義大利（依使用情況）
  • 西班牙（透過申請）
  • 斯堪地那維亞（需申請）
  • 其他歐洲國家（需申請）
  • 亞太地區
    • 用途別
    • 透過分銷管道
    • 按國家/次區域
  • 日本（透過申請）
  • 中國（依使用情況）
  • 印度（依使用情況）
  • 澳洲（按使用情況）
  • 東南亞（需申請）
  • 其他亞太地區（需申請）
  • 拉丁美洲
    • 用途別
    • 透過分銷管道
    • 按國家/次區域
  • 巴西（依使用情況）
  • 墨西哥（按使用情況）
  • 其他拉丁美洲國家（依使用情況）
  • 中東和非洲
    • 用途別
    • 透過分銷管道
    • 按國家/次區域
  • GCC（透過申請）
  • 南非（依使用情況）
  • 其他中東和非洲地區（依使用情況）

目錄

第1章：引言

第2章摘要整理

第3章 市場動態

  • 市場促進因素
  • 市場限制因素
  • 市場機遇

第4章：主要考慮因素

  • 主要國家/地區女性健康問題的盛行率
  • 新產品發布
  • 重大併購、收購與合作
  • 主要行業趨勢
  • 新冠疫情對女性健康市場的影響

第5章：2021-2034年全球女性健康市場分析、洞察與預測

  • 主要發現與總結
  • 市場分析、洞察與預測：按應用領域分類
    • 避孕藥
    • 骨質疏鬆症
    • 停經
    • 不孕症
    • 其他
  • 市場分析、洞察與預測：按分銷管道分類
    • 醫院藥房
    • 零售藥房
    • 網路藥房
  • 市場分析、洞察與預測：按地區分類
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第6章：北美女性健康市場分析、洞察與預測（2021-2034年）

  • 國家
    • 美國
    • 加拿大

第7章：歐洲女性健康市場分析、洞察與預測（2021-2034年）

  • 國家
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪地那維亞
    • 其他歐洲國家

第8章：亞太地區女性健康市場分析、洞察與預測（2021-2034年）

  • 國家
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 東南亞
    • 其他亞太國家

第9章：拉丁美洲女性健康市場分析、洞察與預測（2021-2034年）

  • 國家
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家

第10章：中東和非洲女性健康市場分析、洞察與預測（2021-2034年）

  • 國家
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲國家

第11章 競爭分析

  • 主要行業趨勢
  • 全球市佔率分析（2025 年）
  • 競爭對手儀表板
  • 主要公司比較分析
  • 公司簡介
    • Bayer AG
    • Pfizer Inc.
    • Amgen Inc.
    • Novartis AG
    • Merck & Co., Inc.
    • Eli Lilly and Company
    • LUPIN
    • AstraZeneca
    • Other Players

第12章 戰略建議

Product Code: FBI101847

Growth Factors of women's health Market

The global women's health market is experiencing steady growth driven by the rising prevalence of women-centric diseases and increasing awareness regarding diagnosis, prevention, and treatment. According to the report, the global women's health market size was valued at USD 56.85 billion in 2025. The market is projected to be worth USD 60.44 billion in 2026 and reach USD 98.61 billion by 2034, exhibiting a CAGR of 6.31% during the forecast period. In 2025, North America dominated the market with a share of 51.4%, supported by high healthcare expenditure, strong adoption of women's health products, advanced healthcare infrastructure, and the rising prevalence of women-centric diseases.

Women's health includes healthcare products and treatments addressing conditions such as breast cancer, osteoporosis, menopause, infertility, contraception, and other reproductive and health-related conditions. Growing awareness programs, product launches, collaborations, and investments by pharmaceutical companies are contributing to market development.

Market Definition and Scope

The women's health market covers pharmaceutical products and healthcare solutions designed specifically to address women's medical requirements. Major application areas include contraceptives, osteoporosis, menopause, infertility, and other women's health conditions.

The market scope also includes distribution through hospital pharmacies, retail pharmacies, and online pharmacies. Increasing adoption of preventive healthcare, early diagnosis, reproductive health services, and specialized treatments is expanding the market across developed and emerging economies.

Market Dynamics

Drivers

The increasing prevalence of women-centric diseases and rising healthcare awareness is a major driver of market growth. Conditions such as breast cancer, osteoporosis, anemia, menopause, and infertility are increasing demand for specialized treatments. Greater awareness regarding early diagnosis and preventive healthcare is encouraging women to seek appropriate medical services.

Awareness campaigns and healthcare programs are also supporting adoption. The rising incidence of osteoporosis among women and the significant global burden of breast cancer are encouraging pharmaceutical companies and healthcare organizations to expand treatment and awareness initiatives.

Trends

A prominent market trend is the increasing number of strategic collaborations and acquisitions by market players. Companies are strengthening their women's healthcare portfolios through partnerships, acquisitions, and product commercialization. Bayer's acquisition of KaNDy Therapeutics strengthened its portfolio in menopause treatment, while other pharmaceutical companies have expanded their women's healthcare offerings through strategic transactions.

The growing emphasis on specialized reproductive health and innovative treatments is also influencing Women's Health Market Trends.

Restraints

The harmful effects and potential side effects associated with certain women's healthcare products can restrain market growth. Contraceptive pills may cause spotting, breast tenderness, nausea, and headaches. Some osteoporosis treatments may also cause adverse effects, while certain medicines may carry cardiovascular risks. Such concerns can influence treatment decisions and limit adoption of some products.

Impact of COVID-19

The COVID-19 pandemic negatively affected the women's health market during the early stages of the outbreak. Lockdowns, healthcare restrictions, postponed non-urgent treatments, and reduced hospital visits affected pharmaceutical sales. Bayer, for instance, reported an 8.8% decline in pharmaceutical sales, with its business affected by canceled and postponed treatments.

Changes in patient purchasing behavior also affected the market, as some patients preferred purchasing medicines rather than visiting hospitals because of concerns regarding coronavirus infection. However, demand for essential healthcare products and the gradual reopening of healthcare facilities supported market recovery.

Segmentation Analysis

By application, contraceptives dominate the market, accounting for a 34.2% share in 2025. Growth is supported by increasing awareness of reproductive health, demand for birth-control products, and product launches by pharmaceutical companies. The osteoporosis segment held the second-largest position, supported by the increasing prevalence of osteoporosis among women and growing healthcare expenditure.

By distribution channel, hospital pharmacies lead the market because many women's healthcare medicines require prescriptions and medical evaluation by trained professionals. Government investments in hospital infrastructure further support the segment. Meanwhile, online pharmacies are expected to experience rapid growth due to convenience, accessibility, and discounts.

Regional Insights

North America leads the global women's health market, reaching USD 18.00 billion in 2025. Strong healthcare expenditure, high adoption of women's health products, advanced infrastructure, and the prevalence of diseases such as breast cancer support regional dominance.

Europe is the second-largest region, supported by growing awareness of women's diseases and developed healthcare infrastructure. Asia Pacific is expected to record the highest growth rate, driven by increasing awareness, rising healthcare expenditure, and government initiatives in emerging economies such as China and India. Latin America and the Middle East & Africa represent comparatively smaller markets but offer opportunities because of significant untapped demand.

Competitive Landscape

The market is competitive, with major companies focusing on product innovation, collaborations, acquisitions, and distribution expansion. Key players include Bayer AG, Pfizer Inc., Amgen Inc., Novartis AG, Merck & Co., Inc., Eli Lilly and Company, LUPIN, AstraZeneca, and Agile Therapeutics.

Report Coverage

This report provides a comprehensive analysis of the global women's health market, covering market size for 2025, 2026, and 2034, growth drivers, trends, restraints, applications, distribution channels, regional insights, competitive landscape, and key industry developments. The report also highlights emerging Market Opportunities and product-development activities across major women's healthcare categories.

Conclusion

Growing from USD 56.85 billion in 2025 to USD 98.61 billion by 2034, the global women's health market is positioned for continued expansion. Rising prevalence of women-centric diseases, increasing healthcare awareness, strategic collaborations, product innovation, and expanding access to healthcare are expected to support market growth. North America maintains a leading position, while Asia Pacific offers significant growth opportunities. Continued development of specialized treatments, contraceptive products, menopause solutions, osteoporosis therapies, and accessible healthcare services will shape the market outlook through 2034.

Unit Value (USD Billion)

Segmentation Application; Distribution Channel and Geography

By Application

  • Contraceptives
  • Osteoporosis
  • Menopause
  • Infertility
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Geography

  • North America
    • By Application
    • By Distribution Channel
    • By Country
  • USA (By Application)
  • Canada (By Application)
  • Europe
    • By Application
    • By Distribution Channel
    • By Country/Sub-region
  • The UK (By Application)
  • Germany (By Application)
  • France (By Application)
  • Italy (By Application)
  • Spain (By Application)
  • Scandinavia (By Application)
  • Rest of Europe (By Application)
  • Asia Pacific
    • By Application
    • By Distribution Channel
    • By Country/Sub-region
  • Japan (By Application)
  • China (By Application)
  • India (By Application)
  • Australia (By Application)
  • Southeast Asia (By Application)
  • Rest of Asia Pacific (By Application)
  • Latin America
    • By Application
    • By Distribution Channel
    • By Country/Sub-region
  • Brazil (By Application)
  • Mexico (By Application)
  • Rest of Latin America (By Application)
  • The Middle East & Africa
    • By Application
    • By Distribution Channel
    • By Country/Sub-region
  • GCC (By Application)
  • South Africa (By Application)
  • Rest of the MEA (By Application)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities

4. Key Insights

  • 4.1. Prevalence of Women Related Disorders, By Key Countries/Region
  • 4.2. New Product Launches
  • 4.3. Key Mergers, Acquisition, and Partnerships
  • 4.4. Key Industry Trends
  • 4.5. Impact of COVID-19 on Women's Health Market

5. Global Women's Health Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Key Findings / Summary
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Contraceptives
    • 5.2.2. Osteoporosis
    • 5.2.3. Menopause
    • 5.2.4. Infertility
    • 5.2.5. Others
  • 5.3. Market Analysis, Insights and Forecast - By Distribution Channel
    • 5.3.1. Hospital Pharmacies
    • 5.3.2. Retail Pharmacies
    • 5.3.3. Online Pharmacies
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Women's Health Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Key Findings / Summary
  • 6.2. Market Analysis - By Application
    • 6.2.1. Contraceptives
    • 6.2.2. Osteoporosis
    • 6.2.3. Menopause
    • 6.2.4. Infertility
    • 6.2.5. Others
  • 6.3. Market Analysis - By Distribution Channel
    • 6.3.1. Hospital Pharmacies
    • 6.3.2. Retail Pharmacies
    • 6.3.3. Online Pharmacies
  • 6.4. Market Analysis - By Country
    • 6.4.1. U.S.
      • 6.4.1.1. By Application
    • 6.4.2. Canada
      • 6.4.2.1. By Application

7. Europe Women's Health Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Key Findings / Summary
  • 7.2. Market Analysis - By Application
    • 7.2.1. Contraceptives
    • 7.2.2. Osteoporosis
    • 7.2.3. Menopause
    • 7.2.4. Infertility
    • 7.2.5. Others
  • 7.3. Market Analysis - By Distribution Channel
    • 7.3.1. Hospital Pharmacies
    • 7.3.2. Retail Pharmacies
    • 7.3.3. Online Pharmacies
  • 7.4. Market Analysis - By Country/Sub-region
    • 7.4.1. U.K.
      • 7.4.1.1. By Application
    • 7.4.2. Germany
      • 7.4.2.1. By Application
    • 7.4.3. France
      • 7.4.3.1. By Application
    • 7.4.4. Spain
      • 7.4.4.1. By Application
    • 7.4.5. Italy
      • 7.4.5.1. By Application
    • 7.4.6. Scandinavia
      • 7.4.6.1. By Application
    • 7.4.7. Rest of Europe
      • 7.4.7.1. By Application

8. Asia Pacific Women's Health Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Key Findings / Summary
  • 8.2. Market Analysis - By Application
    • 8.2.1. Contraceptives
    • 8.2.2. Osteoporosis
    • 8.2.3. Menopause
    • 8.2.4. Infertility
    • 8.2.5. Others
  • 8.3. Market Analysis - By Distribution Channel
    • 8.3.1. Hospital Pharmacies
    • 8.3.2. Retail Pharmacies
    • 8.3.3. Online Pharmacies
  • 8.4. Market Analysis - By Country/Sub-region
    • 8.4.1. Japan
      • 8.4.1.1. By Application
    • 8.4.2. China
      • 8.4.2.1. By Application
    • 8.4.3. India
      • 8.4.3.1. By Application
    • 8.4.4. Australia
      • 8.4.4.1. By Application
    • 8.4.5. Southeast Asia
      • 8.4.5.1. By Application
    • 8.4.6. Rest of Asia Pacific
      • 8.4.6.1. By Application

9. Latin America Women's Health Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Key Findings / Summary
  • 9.2. Market Analysis - By Application
    • 9.2.1. Contraceptives
    • 9.2.2. Osteoporosis
    • 9.2.3. Menopause
    • 9.2.4. Infertility
    • 9.2.5. Others
  • 9.3. Market Analysis - By Distribution Channel
    • 9.3.1. Hospital Pharmacies
    • 9.3.2. Retail Pharmacies
    • 9.3.3. Online Pharmacies
  • 9.4. Market Analysis - By Country/Sub-region
    • 9.4.1. Brazil
      • 9.4.1.1. By Application
    • 9.4.2. Mexico
      • 9.4.2.1. By Application
    • 9.4.3. Rest of Latin America
      • 9.4.3.1. By Application

10. Middle East & Africa Women's Health Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Key Findings / Summary
  • 10.2. Market Analysis - By Application
    • 10.2.1. Contraceptives
    • 10.2.2. Osteoporosis
    • 10.2.3. Menopause
    • 10.2.4. Infertility
    • 10.2.5. Others
  • 10.3. Market Analysis - By Distribution Channel
    • 10.3.1. Hospital Pharmacies
    • 10.3.2. Retail Pharmacies
    • 10.3.3. Online Pharmacies
  • 10.4. Market Analysis - By Country/Sub-region
    • 10.4.1. GCC Countries
      • 10.4.1.1. By Application
    • 10.4.2. South Africa
      • 10.4.2.1. By Application
    • 10.4.3. Rest of Middle East & Africa
      • 10.4.3.1. By Application

11. Competitive Analysis

  • 11.1. Key Industry Developments
  • 11.2. Global Market Share Analysis (2025)
  • 11.3. Competition Dashboard
  • 11.4. Comparative Analysis - Major Players
  • 11.5. Company Profiles
    • 11.5.1. Bayer AG
      • 11.5.1.1. Overview,
      • 11.5.1.2. Products & Services,
      • 11.5.1.3. SWOT Analysis,
      • 11.5.1.4. Recent Developments,
      • 11.5.1.5. Strategies,
      • 11.5.1.6. Financials (based on availability)
    • 11.5.2. Pfizer Inc.
      • 11.5.2.1. Overview,
      • 11.5.2.2. Products & Services,
      • 11.5.2.3. SWOT Analysis,
      • 11.5.2.4. Recent Developments,
      • 11.5.2.5. Strategies,
      • 11.5.2.6. Financials (based on availability)
    • 11.5.3. Amgen Inc.
      • 11.5.3.1. Overview,
      • 11.5.3.2. Products & Services,
      • 11.5.3.3. SWOT Analysis,
      • 11.5.3.4. Recent Developments,
      • 11.5.3.5. Strategies,
      • 11.5.3.6. Financials (based on availability)
    • 11.5.4. Novartis AG
      • 11.5.4.1. Overview,
      • 11.5.4.2. Products & Services,
      • 11.5.4.3. SWOT Analysis,
      • 11.5.4.4. Recent Developments,
      • 11.5.4.5. Strategies,
      • 11.5.4.6. Financials (based on availability)
    • 11.5.5. Merck & Co., Inc.
      • 11.5.5.1. Overview,
      • 11.5.5.2. Products & Services,
      • 11.5.5.3. SWOT Analysis,
      • 11.5.5.4. Recent Developments,
      • 11.5.5.5. Strategies,
      • 11.5.5.6. Financials (based on availability)
    • 11.5.6. Eli Lilly and Company
      • 11.5.6.1. Overview,
      • 11.5.6.2. Products & Services,
      • 11.5.6.3. SWOT Analysis,
      • 11.5.6.4. Recent Developments,
      • 11.5.6.5. Strategies,
      • 11.5.6.6. Financials (based on availability)
    • 11.5.7. LUPIN
      • 11.5.7.1. Overview,
      • 11.5.7.2. Products & Services,
      • 11.5.7.3. SWOT Analysis,
      • 11.5.7.4. Recent Developments,
      • 11.5.7.5. Strategies,
      • 11.5.7.6. Financials (based on availability)
    • 11.5.8. AstraZeneca
      • 11.5.8.1. Overview,
      • 11.5.8.2. Products & Services,
      • 11.5.8.3. SWOT Analysis,
      • 11.5.8.4. Recent Developments,
      • 11.5.8.5. Strategies,
      • 11.5.8.6. Financials (based on availability)
    • 11.5.9. Other Players
      • 11.5.9.1. Overview,
      • 11.5.9.2. Products & Services,
      • 11.5.9.3. SWOT Analysis,
      • 11.5.9.4. Recent Developments,
      • 11.5.9.5. Strategies,
      • 11.5.9.6. Financials (based on availability)

12. Strategic Recommendations

List of Tables

  • Table 1: Global Women's Health Market Revenue (US$ Bn) Forecast, by Application, 2021-2034
  • Table 2: Global Women's Health Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2021-2034
  • Table 3: Global Women's Health Market Revenue (US$ Bn) Forecast, by Region, 2021-2034
  • Table 4: North America Women's Health Market Revenue (US$ Bn) Forecast, by Application, 2021-2034
  • Table 5: North America Women's Health Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2021-2034
  • Table 6: North America Women's Health Market Revenue (US$ Bn) Forecast, By Country, 2021-2034
  • Table 7: Europe Women's Health Market Revenue (US$ Bn) Forecast, by Application, 2021-2034
  • Table 8: Europe Women's Health Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2021-2034
  • Table 9: Europe Women's Health Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2021-2034
  • Table 10: Asia Pacific Women's Health Market Revenue (US$ Bn) Forecast, by Application, 2021-2034
  • Table 11: Asia Pacific Women's Health Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2021-2034
  • Table 12: Asia Pacific Women's Health Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2021-2034
  • Table 13: Latin America Women's Health Market Revenue (US$ Bn) Forecast, by Application, 2021-2034
  • Table 14: Latin America Women's Health Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2021-2034
  • Table 15: Latin America Women's Health Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2021-2034
  • Table 16: Middle East & Africa Women's Health Market Revenue (US$ Bn) Forecast, by Application, 2021-2034
  • Table 17: Middle East & Africa Women's Health Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2021-2034
  • Table 18: Middle East & Africa Women's Health Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Women's Health Market Revenue Breakdown (US$ Bn, %) by Region, 2025 & 2034
  • Figure 2: Global Women's Health Market Value Share (%), by Application, 2025 & 2034
  • Figure 3: Global Women's Health Market Forecast (US$ Bn), by Contraceptives, 2021-2034
  • Figure 4: Global Women's Health Market Forecast (US$ Bn), by Osteoporosis, 2021-2034
  • Figure 5: Global Women's Health Market Forecast (US$ Bn), by Menopause, 2021-2034
  • Figure 6: Global Women's Health Market Forecast (US$ Bn), by Infertility, 2021-2034
  • Figure 7: Global Women's Health Market Forecast (US$ Bn), by Others, 2021-2034
  • Figure 8: Global Women's Health Market Value Share (%), by Distribution Channel, 2025 & 2034
  • Figure 9: Global Women's Health Market Forecast (US$ Bn), by Hospital Pharmacies, 2021-2034
  • Figure 10: Global Women's Health Market Forecast (US$ Bn), by Retail Pharmacies, 2021-2034
  • Figure 11: Global Women's Health Market Forecast (US$ Bn), by Online Pharmacies, 2021-2034
  • Figure 12: Global Women's Health Market Value (US$ Bn), by Region, 2025 & 2034
  • Figure 13: North America Women's Health Market Value (US$ Bn), by Application, 2025 & 2034
  • Figure 14: North America Women's Health Market Value Share (%), by Application, 2025
  • Figure 15: North America Women's Health Market Value (US$ Bn), by Distribution Channel, 2025 & 2034
  • Figure 16: North America Women's Health Market Value Share (%), by Distribution Channel, 2025
  • Figure 17: North America Women's Health Market Value (US$ Bn), By Country, 2025 & 2034
  • Figure 18: North America Women's Health Market Value Share (%), By Country, 2025
  • Figure 19: Europe Women's Health Market Value (US$ Bn), by Application, 2025 & 2034
  • Figure 20: Europe Women's Health Market Value Share (%), by Application, 2025
  • Figure 21: Europe Women's Health Market Value (US$ Bn), by Distribution Channel, 2025 & 2034
  • Figure 22: Europe Women's Health Market Value Share (%), by Distribution Channel, 2025
  • Figure 23: Europe Women's Health Market Value (US$ Bn), By Country/ Sub-region, 2025 & 2034
  • Figure 24: Europe Women's Health Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 25: Asia Pacific Women's Health Market Value (US$ Bn), by Application, 2025 & 2034
  • Figure 26: Asia Pacific Women's Health Market Value Share (%), by Application, 2025
  • Figure 27: Asia Pacific Women's Health Market Value (US$ Bn), by Distribution Channel, 2025 & 2034
  • Figure 28: Asia Pacific Women's Health Market Value Share (%), by Distribution Channel, 2025
  • Figure 29: Asia Pacific Women's Health Market Value (US$ Bn), By Country/ Sub-region, 2025 & 2034
  • Figure 30: Asia Pacific Women's Health Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 31: Latin America Women's Health Market Value (US$ Bn), by Application, 2025 & 2034
  • Figure 32: Latin America Women's Health Market Value Share (%), by Application, 2025
  • Figure 33: Latin America Women's Health Market Value (US$ Bn), by Distribution Channel, 2025 & 2034
  • Figure 34: Latin America Women's Health Market Value Share (%), by Distribution Channel, 2025
  • Figure 35: Latin America Women's Health Market Value (US$ Bn), By Country/ Sub-region, 2025 & 2034
  • Figure 36: Latin America Women's Health Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 37: Middle East & Africa Women's Health Market Value (US$ Bn), by Application, 2025 & 2034
  • Figure 38: Middle East & Africa Women's Health Market Value Share (%), by Application, 2025
  • Figure 39: Middle East & Africa Women's Health Market Value (US$ Bn), by Distribution Channel, 2025 & 2034
  • Figure 40: Middle East & Africa Women's Health Market Value Share (%), by Distribution Channel, 2025
  • Figure 41: Middle East & Africa Women's Health Market Value (US$ Bn), By Country/ Sub-region, 2025 & 2034
  • Figure 42: Middle East & Africa Women's Health Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 43: Global Women's Health Market Share (%), By Company, 2025